US Stock MarketDetailed Quotes
OKUR OnKure Therapeutics
- 14.760
- -0.260-1.73%
Close Nov 27 16:00 ET
196.89MMarket Cap-1553P/E (TTM)
15.660High14.450Low95.52KVolume15.380Open15.020Pre Close1.42MTurnover5.29%Turnover RatioLossP/E (Static)13.34MShares77.60052wk High1.50P/B26.67MFloat Cap9.80152wk Low--Dividend TTM1.81MShs Float171.799Historical High--Div YieldTTM8.06%Amplitude9.801Historical Low14.853Avg Price1Lot Size
OnKure Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||||
| Gross profit | |||||||||
| Operating expense | -77.67%4.66M | 66.12%14.34M | 12.33%9.83M | 24.08%36.93M | -21.11M | 20.89M | 8.63M | 8.75M | 29.77M |
| Selling and administrative expenses | -48.25%3.76M | 220.63%3.59M | 2.93%1.27M | 23.44%4.82M | ---14.22M | --7.27M | --1.12M | --1.23M | --3.9M |
| -General and administrative expense | -48.25%3.76M | 220.63%3.59M | 2.93%1.27M | 23.44%4.82M | ---14.22M | --7.27M | --1.12M | --1.23M | --3.9M |
| Research and development costs | -93.36%904K | 43.09%10.75M | 13.86%8.57M | 24.18%32.12M | ---6.89M | --13.62M | --7.51M | --7.52M | --25.86M |
| Operating profit | 77.67%-4.66M | -66.12%-14.34M | -12.33%-9.83M | -24.08%-36.93M | 21.11M | -20.89M | -8.63M | -8.75M | -29.77M |
| Net non-operating interest income expense | -54.77%204K | 304.11%295K | 538.98%1.62M | 451K | 73K | 254K | |||
| Non-operating interest income | ---- | -49.00%230K | 304.11%295K | 538.98%1.62M | ---- | ---- | --451K | --73K | --254K |
| Non-operating interest expense | ---- | --26K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other net income (expense) | -42.55%972K | 1.69M | |||||||
| Other non- operating income (expenses) | -42.55%972K | ---- | ---- | ---- | ---- | --1.69M | ---- | ---- | ---- |
| Income before tax | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M | -29.51M |
| Income tax | |||||||||
| Net income | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M | -29.51M |
| Net income continuous Operations | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | --18.52M | ---19.2M | ---8.18M | ---8.68M | ---29.51M |
| Minority interest income | |||||||||
| Net income attributable to the parent company | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M | -29.51M |
| Preferred stock dividends | |||||||||
| Other preferred stock dividends | |||||||||
| Net income attributable to common stockholders | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M | -29.51M |
| Basic earnings per share | 80.77%-0.2768 | -72.79%-1.0599 | -9.87%-0.7149 | -19.65%-2.6471 | 1.3886 | -1.439 | -0.6134 | -0.6506 | -2.2124 |
| Diluted earnings per share | 80.77%-0.2768 | -72.79%-1.0599 | -9.87%-0.7149 | -19.65%-2.6471 | 1.3886 | -1.439 | -0.6134 | -0.6506 | -2.2124 |
| Dividend per share | |||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data